Cardlytics, Inc. (NASDAQ:CDLX – Get Free Report) CEO Amit Gupta sold 6,676 shares of the business’s stock in a transaction on Tuesday, August 18th. The shares were sold at an average price of $4.03, for a total transaction of $26,904.28. Following the completion of the sale, the chief executive officer directly owned 125,389 shares in the company, valued at $505,317.67. This represents a 5.06% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink.
Amit Gupta also recently made the following trade(s):
- On Monday, August 17th, Amit Gupta sold 6,785 shares of Cardlytics stock. The stock was sold at an average price of $3.97, for a total value of $26,936.45.
- On Monday, July 6th, Amit Gupta sold 9,640 shares of Cardlytics stock. The shares were sold at an average price of $4.39, for a total value of $42,319.60.
- On Thursday, July 2nd, Amit Gupta sold 6,498 shares of Cardlytics stock. The stock was sold at an average price of $4.39, for a total value of $28,526.22.
Cardlytics Stock Performance
Cardlytics stock traded up $0.07 during midday trading on Tuesday, reaching $4.12. The stock had a trading volume of 53,338 shares, compared to its average volume of 93,274. The stock has a market capitalization of $23.94 million, a P/E ratio of -0.22 and a beta of 0.62. The firm’s fifty day simple moving average is $4.37 and its 200-day simple moving average is $7.04. Cardlytics, Inc. has a 1-year low of $3.49 and a 1-year high of $32.80.
Analyst Upgrades and Downgrades
Several equities research analysts have commented on CDLX shares. Needham & Company LLC reissued a “hold” rating on shares of Cardlytics in a research report on Thursday, June 18th. Lake Street Capital set a $10.00 target price on Cardlytics in a research report on Friday, May 8th. Wall Street Zen upgraded Cardlytics from a “sell” rating to a “hold” rating in a report on Saturday, August 8th. Finally, Weiss Ratings reissued a “sell (e+)” rating on shares of Cardlytics in a research report on Wednesday, July 8th. One analyst has rated the stock with a Hold rating and two have given a Sell rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Sell” and a consensus target price of $10.00.
Get Our Latest Stock Report on CDLX
Institutional Inflows and Outflows
Several institutional investors have recently modified their holdings of the company. Goldman Sachs Group Inc. lifted its stake in Cardlytics by 15.1% in the 4th quarter. Goldman Sachs Group Inc. now owns 109,001 shares of the company’s stock valued at $125,000 after purchasing an additional 14,273 shares during the last quarter. Geode Capital Management LLC raised its stake in Cardlytics by 3.3% in the fourth quarter. Geode Capital Management LLC now owns 654,472 shares of the company’s stock valued at $753,000 after buying an additional 20,908 shares during the period. Qube Research & Technologies Ltd acquired a new stake in shares of Cardlytics in the third quarter valued at approximately $55,000. Boothbay Fund Management LLC bought a new position in shares of Cardlytics during the 3rd quarter worth approximately $74,000. Finally, Virtu Financial LLC bought a new position in shares of Cardlytics during the 4th quarter worth approximately $39,000. 68.10% of the stock is currently owned by institutional investors and hedge funds.
Cardlytics Company Profile
Cardlytics, Inc operates a purchase intelligence and marketing platform that connects advertisers with consumers through bank and credit card transaction data. The company partners with financial institutions to analyze anonymized purchase information, enabling brands to deliver highly targeted offers and rewards directly to customers’ online and mobile banking channels. By leveraging real-time insights into consumer spending habits, Cardlytics helps marketers optimize campaign performance and measure return on ad spend more accurately than traditional digital advertising methods.
At the core of Cardlytics’ offering is its proprietary purchase intelligence engine, which aggregates and anonymizes transaction data from partner banks and credit unions.
See Also
- Five stocks we like better than Cardlytics
- The AI Boom Is Turning This Cable Maker Into a Stock to Watch
- A Star Investor Just Trimmed Amazon—Here’s What It means
- Wendy’s Deal Buzz May Give Fast-Food Investors a New Reason to Look
- Home Depot Analysts See a Path to $375 and Beyond
Receive News & Ratings for Cardlytics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardlytics and related companies with MarketBeat.com's FREE daily email newsletter.
